Massachusetts Financial Services’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$197M Sell
3,733,248
-279,570
-7% -$16.8M 0.07% 254
2025
Q4
$236M Buy
4,012,818
+2,495,328
+164% +$152M 0.08% 233
2025
Q3
$84.4M Sell
1,517,490
-138,448
-8% -$7.42M 0.03% 391
2025
Q2
$85.2M Sell
1,655,938
-1,369,471
-45% -$68.8M 0.03% 398
2025
Q1
$177M Buy
3,025,409
+472,847
+19% +$32M 0.06% 295
2024
Q4
$184M Sell
2,552,562
-28,240
-1% -$2.07M 0.06% 290
2024
Q3
$206M Sell
2,580,802
-8,997
-0.3% -$676K 0.06% 276
2024
Q2
$186M Buy
2,589,799
+88,257
+4% +$6.5M 0.06% 276
2024
Q1
$176M Buy
2,501,542
+1,716,999
+219% +$123M 0.05% 293
2023
Q4
$60.5M Buy
784,543
+731,869
+1,389% +$48.2M 0.02% 430
2023
Q3
$3.59M Sell
52,674
-132
-0.2% -$10.4K ﹤0.01% 678
2023
Q2
$4.31M Sell
52,806
-345,134
-87% -$27.7M ﹤0.01% 655
2023
Q1
$29.5M Sell
397,940
-746,091
-65% -$57.5M 0.01% 510
2022
Q4
$94.8M Sell
1,144,031
-50,853
-4% -$4.04M 0.03% 364
2022
Q3
$84.8M Sell
1,194,884
-704,524
-37% -$60.9M 0.03% 364
2022
Q2
$165M Sell
1,899,408
-285,292
-13% -$26.7M 0.06% 274
2022
Q1
$237M Sell
2,184,700
-727,440
-25% -$75.1M 0.07% 239
2021
Q4
$377M Sell
2,912,140
-289,576
-9% -$35.5M 0.1% 183
2021
Q3
$388M Sell
3,201,716
-28,660
-0.9% -$3.49M 0.11% 173
2021
Q2
$364M Sell
3,230,376
-388,856
-11% -$40.9M 0.11% 182
2021
Q1
$346M Sell
3,619,232
-63,356
-2% -$5.78M 0.11% 179
2020
Q4
$292M Buy
3,682,588
+149,364
+4% +$10.8M 0.09% 194
2020
Q3
$219M Buy
3,533,224
+114,216
+3% +$7.43M 0.08% 208
2020
Q2
$226M Sell
3,419,008
-141,488
-4% -$8.47M 0.09% 196
2020
Q1
$169M Buy
3,560,496
+340,888
+11% +$17.1M 0.08% 199
2019
Q4
$177M Sell
3,219,608
-585,596
-15% -$30.7M 0.07% 228
2019
Q3
$186M Buy
3,805,204
+126,800
+3% +$6.36M 0.07% 212
2019
Q2
$192M Buy
3,678,404
+255,904
+7% +$12.9M 0.08% 206
2019
Q1
$170M Buy
3,422,500
+207,968
+6% +$9.36M 0.07% 217
2018
Q4
$116M Buy
3,214,532
+502,660
+19% +$21M 0.06% 238
2018
Q3
$138M Buy
2,711,872
+319,852
+13% +$14.2M 0.06% 238
2018
Q2
$88.5M Buy
2,392,020
+539,084
+29% +$20.6M 0.04% 298
2018
Q1
$70M Buy
1,852,936
+1,502,516
+429% +$53.1M 0.03% 335
2017
Q4
$11.3M Buy
350,420
+4,616
+1% +$147K ﹤0.01% 591
2017
Q3
$10.5M Sell
345,804
-51,264
-13% -$1.52M ﹤0.01% 597
2017
Q2
$11.7M Sell
397,068
-39,480
-9% -$1.08M 0.01% 579
2017
Q1
$11.1M Buy
436,548
+102,060
+31% +$2.63M 0.01% 573
2016
Q4
$8.6M Buy
+334,488
New +$8.79M ﹤0.01% 612

Other funds holding TECH

Massachusetts Financial Services's TECH Position: Q1 2026 in Review

Massachusetts Financial Services reduced its Bio-Techne (TECH) stake by 7% in Q1 2026, selling an estimated $16.8M and leaving 3,733,248 shares worth $197M. The position accounts for 0.07% of the portfolio, ranked #254.

Massachusetts Financial Services first reported a position in TECH in Q4 2016 and has held it in 38 quarters since. The position peaked at $388M in Q3 2021. 582 funds tracked by Wall St. Rank hold TECH as of Q1 2026.

  • Massachusetts Financial Services held 3,733,248 shares of Bio-Techne worth $197M as of Q1 2026.
  • Massachusetts Financial Services sold 279,570 Bio-Techne shares in Q1 2026, an estimated $16.8M.
  • Bio-Techne made up 0.07% of Massachusetts Financial Services's portfolio in Q1 2026, its #254 holding.
  • Massachusetts Financial Services first reported a position in Bio-Techne in Q4 2016 and has held it in 38 quarters since.
  • Massachusetts Financial Services's Bio-Techne position peaked at $388M in Q3 2021.
  • 582 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2026.

Based on Massachusetts Financial Services's 13F filing for Q1 2026, filed 14 May 2026.